{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:08:08Z","timestamp":1775192888329,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01856-z","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:43:37Z","timestamp":1761893017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The ovarian response to stimulation in patients with lymphoma (Hodgkin and non-Hodgkin); a retrospective age-matched control study"],"prefix":"10.1007","volume":"25","author":[{"given":"Toktam","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azar","family":"Yahyaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hafezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firouzeh","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"6","key":"1856_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/17474086.2019.1613150","volume":"12","author":"M Salama","year":"2019","unstructured":"Salama M, Anazodo A, Woodruff TK. Preserving fertility in female patients with hematological malignancies: the key points. Expert Rev Hematol. 2019;12(6):375\u20137.","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"1856_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R. Molecular biology of Hodgkin lymphoma. Leukemia. 2021;35(4):968\u201381.","journal-title":"Leukemia"},{"issue":"12","key":"1856_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ajh.26719","volume":"97","author":"MS Alabdaljabar","year":"2022","unstructured":"Alabdaljabar MS, Durani U, Thompson CA, Constine LS, Hashmi SK. The forgotten survivor: a comprehensive review on non-Hodgkin lymphoma survivorship. Am J Hematol. 2022;97(12):1627\u201337.","journal-title":"Am J Hematol"},{"issue":"4","key":"1856_CR4","first-page":"226","volume":"2","author":"J Luo","year":"2022","unstructured":"Luo J, Craver A, Bahl K, Stepniak L, Moore K, King J, et al. Etiology of non-Hodgkin lymphoma: a review from epidemiologic studies. J Natl Cancer Cent. 2022;2(4):226\u201334.","journal-title":"J Natl Cancer Cent"},{"issue":"7","key":"1856_CR5","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBDO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"key":"1856_CR6","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","volume":"13","author":"Y Chu","year":"2023","unstructured":"Chu Y, Liu Y, Fang X, Jiang Y, Ding M, Ge X, et al. The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Front Oncol. 2023;13:1059914.","journal-title":"Front Oncol"},{"issue":"1","key":"1856_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","volume":"15","author":"J Huang","year":"2022","unstructured":"Huang J, Pang WS, Lok V, Zhang L, Lucero-Prisno DE III, Xu W, et al. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. J Hematol Oncol. 2022;15(1):57.","journal-title":"J Hematol Oncol"},{"key":"1856_CR8","doi-asserted-by":"publisher","first-page":"1252433","DOI":"10.3389\/fonc.2023.1252433","volume":"13","author":"C Minoia","year":"2023","unstructured":"Minoia C, Viviani S, Silvestris E, Palini S, Parissone F, De Palma G, et al. Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Societ\u00e0 Italiana della Riproduzione Umana. Front Oncol. 2023;13:1252433.","journal-title":"Front Oncol"},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00404-017-4594-3","volume":"297","author":"A Sch\u00fcring","year":"2018","unstructured":"Sch\u00fcring A, Fehm T, Behringer K, Goeckenjan M, Wimberger P, Henes M, et al. Practical recommendations for fertility preservation in women by the Ferti PROTEKT network. Part I: indications for fertility preservation. Arch Gynecol Obstet. 2018;297:241\u201355.","journal-title":"Arch Gynecol Obstet"},{"key":"1856_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.942122","volume":"12","author":"S Xie","year":"2022","unstructured":"Xie S, Yu Z, Feng A, Zheng S, Li Y, Zeng Y, et al. Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method. Front Oncol. 2022;12:942122.","journal-title":"Front Oncol"},{"issue":"4","key":"1856_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/humupd\/dmad002","volume":"29","author":"KC Drechsel","year":"2023","unstructured":"Drechsel KC, Pilon MC, Stoutjesdijk F, Meivis S, Schoonmade LJ, Wallace WHB, et al. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review. Hum Reprod Update. 2023;29(4):486\u2013517.","journal-title":"Hum Reprod Update"},{"issue":"8","key":"1856_CR12","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s12094-024-03419-2","volume":"26","author":"D Li","year":"2024","unstructured":"Li D, Zhao Y-j, Wang Q, Chu M-w, Xie J-k, Zhang C-l. Fertility preservation in hematological cancer patients. Clin Transl Oncol. 2024;26(8):1836\u201343.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"1856_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/bjh.18938","volume":"202","author":"JP Entrop","year":"2023","unstructured":"Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, \u00d8vlisen AK, Glimelius I, et al. Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: a population-based matched cohort study. Br J Haematol. 2023;202(4):785\u201395.","journal-title":"Br J Haematol"},{"issue":"12","key":"1856_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122881","volume":"13","author":"S Viviani","year":"2021","unstructured":"Viviani S, Caccavari V, Gerardi C, Ramadan S, Allocati E, Minoia C, et al. Male and female fertility: prevention and monitoring Hodgkin\u2019lymphoma and diffuse large B-cell lymphoma adult survivors. A systematic review by the Fondazione Italiana Linfomi. Cancers. 2021;13(12):2881.","journal-title":"Cancers"},{"issue":"2","key":"1856_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.103978","volume":"49","author":"T Katzir","year":"2024","unstructured":"Katzir T, Shrem G, Meirow D, Berkowitz E, Elizur S, Cohen S, et al. Fertility preservation parameters in patients with haematologic malignancy: a systematic review and meta-analysis. Reprod Biomed Online. 2024;49(2):103978.","journal-title":"Reprod Biomed Online"},{"key":"1856_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101115","volume":"62","author":"MB Antunes","year":"2023","unstructured":"Antunes MB, Cardeal SP, Magalh\u00e3es M, Vale-Fernandes E, Barreiro M, Sa R, et al. Preservation of fertility in female patients with hematologic diseases. Blood Rev. 2023;62:101115.","journal-title":"Blood Rev"},{"issue":"1","key":"1856_CR17","first-page":"1","volume":"19","author":"A Yahyaei","year":"2025","unstructured":"Yahyaei A, Mashhadi Meighani E, Ghaffari F. Fertility preservation in female patients with cancer part II: Royan Institute clinical practice guideline for girls and women with cancer; a review study. Int J Fertil Steril. 2025;19(1):1.","journal-title":"Int J Fertil Steril"},{"key":"1856_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.574263","volume":"11","author":"RA Anderson","year":"2020","unstructured":"Anderson RA, Su HI. The clinical value and interpretation of anti-M\u00fcllerian hormone in women with cancer. Front Endocrinol. 2020;11:574263.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1856_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.rbmo.2019.06.001","volume":"39","author":"K Palinska-Rudzka","year":"2019","unstructured":"Palinska-Rudzka K, Ghobara T, Parsons N, Milner J, Lockwood G, Hartshorne GM. Five-year study assessing the clinical utility of anti-M\u00fcllerian hormone measurements in reproductive-age women with cancer. Reprod Biomed Online. 2019;39(4):712\u201320.","journal-title":"Reprod Biomed Online"},{"key":"1856_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-016-0689-1","volume":"33","author":"J Lekovich","year":"2016","unstructured":"Lekovich J, Lobel AL, Stewart JD, Pereira N, Kligman I, Rosenwaks Z. Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies. J Assist Reprod Genet. 2016;33:657\u201362.","journal-title":"J Assist Reprod Genet"},{"key":"1856_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.104448","author":"V Simon","year":"2025","unstructured":"Simon V, Chuzel C, Behal H, Labreuche J, Manier S, Morschhauser F, et al. Is there a relationship between tumour aggressiveness and ovarian stimulation outcomes in adolescent and young adult patients with lymphoma? Reprod Biomed Online. 2025. https:\/\/doi.org\/10.1016\/j.rbmo.2024.104448.","journal-title":"Reprod Biomed Online"},{"key":"1856_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10815-018-1227-0","volume":"35","author":"M von Wolff","year":"2018","unstructured":"von Wolff M, Bruckner T, Strowitzki T, Germeyer A. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases\u2014an analysis of 992 stimulations. J Assist Reprod Genet. 2018;35:1713\u20139.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"1856_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","volume":"98","author":"B Lawrenz","year":"2012","unstructured":"Lawrenz B, Fehm T, von Wolff M, Soekler M, Huebner S, Henes J, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma\u2014evaluation by using antim\u00fcllerian hormone and retrieved oocytes. Fertil Steril. 2012;98(1):141\u20134.","journal-title":"Fertil Steril"},{"issue":"5","key":"1856_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.fertnstert.2016.06.035","volume":"106","author":"R Paradisi","year":"2016","unstructured":"Paradisi R, Vicenti R, Macciocca M, Seracchioli R, Rossi S, Fabbri R. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma. Fertil Steril. 2016;106(5):1176\u201382.","journal-title":"Fertil Steril"},{"key":"1856_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10815-017-1059-3","volume":"35","author":"C Sonigo","year":"2018","unstructured":"Sonigo C, Comtet M, Duros S, Sifer C, Sermondade N, Grynberg M. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin\u2019s lymphoma when compared with breast cancer candidates for fertility preservation. J Assist Reprod Genet. 2018;35:91\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"1856_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.rbmo.2021.08.007","volume":"43","author":"A Caponnetto","year":"2021","unstructured":"Caponnetto A, Battaglia R, Ragusa M, Barbagallo D, Lunelio F, Borz\u00ec P, et al. Molecular profiling of follicular fluid microRNAs in young women affected by Hodgkin lymphoma. Reprod Biomed Online. 2021;43(6):1045\u201356.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"1856_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1089\/jayao.2022.0069","volume":"13","author":"V Kocsuta","year":"2024","unstructured":"Kocsuta V, Shah S, Lawson AK, Pavone ME. Do fertility preservation outcomes in patients diagnosed with lymphoma differ based on cancer stage? J Adolesc Young Adult Oncol. 2024;13(2):300\u20136.","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"2","key":"1856_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.fertnstert.2019.09.033","volume":"113","author":"A Volodarsky-Perel","year":"2020","unstructured":"Volodarsky-Perel A, Tulandi T, Son W-Y, Khojah M, Buckett W. Impact of extent and biochemical parameters of lymphoma on fertility preservation outcome. Fertility Sterility. 2020;113(2):400-7.e1.","journal-title":"Fertility Sterility."},{"issue":"5","key":"1856_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101925","volume":"50","author":"T Brun","year":"2021","unstructured":"Brun T, Dion L, Jaillard S, Bales D, Domin M, Lavou\u00e9 V, et al. Ovarian response to stimulation for fertility preservation in women with hematologic cancer. J Gynecol Obstet Hum Reprod. 2021;50(5):101925.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"12","key":"1856_CR30","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1093\/humrep\/dez215","volume":"34","author":"J Liebenthron","year":"2019","unstructured":"Liebenthron J, Reinsberg J, Van Der Ven K, Saenger N, Kruessel J, von Wolff M. Serum anti-M\u00fcllerian hormone concentration and follicle density throughout reproductive life and in different diseases\u2014implications in fertility preservation. Hum Reprod. 2019;34(12):2513\u201322.","journal-title":"Hum Reprod"},{"key":"1856_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1481546","volume":"15","author":"H Verschuere","year":"2024","unstructured":"Verschuere H, Laenen A, Debrock S, Tomassetti C, Lie Fong S. Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment. Front Endocrinol. 2024;15:1481546.","journal-title":"Front Endocrinol"},{"key":"1856_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.640047","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Liu S, Su H, Hua L, Ren H, Liu M, et al. Low serum LH levels during ovarian stimulation with GnRH antagonist protocol decrease the live birth rate after fresh embryo transfers but have no impact in freeze-all cycles. Front Endocrinol. 2021;12:640047.","journal-title":"Front Endocrinol"},{"key":"1856_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.831859","volume":"13","author":"M-H Yan","year":"2022","unstructured":"Yan M-H, Cao J-X, Hou J-W, Jiang W-J, Wang D-D, Sun Z-G, et al. GnRH agonist and hCG (dual trigger) versus hCG trigger for final oocyte maturation in expected normal responders with a high immature oocyte rate: study protocol for a randomized, superiority, parallel group, controlled trial. Front Endocrinol. 2022;13:831859.","journal-title":"Front Endocrinol"},{"key":"1856_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10815-014-0248-6","volume":"31","author":"J Reddy","year":"2014","unstructured":"Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet. 2014;31:927\u201332.","journal-title":"J Assist Reprod Genet"},{"key":"1856_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejogrb.2017.09.004","volume":"218","author":"N Ding","year":"2017","unstructured":"Ding N, Liu X, Jian Q, Liang Z, Wang F. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;218:92\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01856-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:51:34Z","timestamp":1764917494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01856-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01856-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards committee of the ROYAN Institute and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.Ethics Approval Code: IR.ACECR.ROYAN.REC.IR.ACECR.ROYAN.REC.1402.129.Date: 02\/21\/2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"346"}}